Anavex agreement with The Roskamp Institute to advance the clinical development of ANAVEX PLUS

Anavex Life Sciences Corp. has announced that they have established an agreement with The Roskamp Institute for the clinical development of ANAVEX PLUS, a new combination drug of ANAVEX 2-73 and donepezil (Aricept

Leave a Reply